Figure 3. Re-expression of UGTs in SKmel28 cells in response to epirubicin and vemurafenib.

Predesigned Taqman gene expression assays were used to visualize individual UGT expression by real-time PCR following treatment of SKmel28 cells with (A) epirubicin or (B) vemurafenib. Time course of UGT2B expression following epirubicin (100 nM) or vemurafenib (1 µM) treatment was examined at 0, 8, 16 and 24 hrs. * indicates different scale for y-axis. ND = not detected.